David Gallagher
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- PARP inhibition in cancer therapy
Papers in
- Co-authors
- Nancy E. Kemeny (8 shared papers)Matthew I. Milowsky (16 shared papers)Dean F. Bajorin (18 shared papers)Jamie C. Riches (11 shared papers)A. Trout (8 shared papers)Nicole Ishill (4 shared papers)Jasmine Bhatia (5 shared papers)Ashley Marie Regazzi (9 shared papers)
- Journals
- Journal of Clinical Oncology (23 papers)Annals of Oncology (7 papers)Familial Cancer (4 papers)Clinical Colorectal Cancer (4 papers)The Journal of Urology (3 papers)
- Partner nations
- IrelandUnited StatesUnited Kingdom
In The Last Decade
David Gallagher
95 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 95
- Hepatology 165
- Oncology 504
- Cancer Research 213
- Pulmonary and Respiratory Medicine 391
- Surgery 463
Countries citing papers authored by David Gallagher
This map shows the geographic impact of David Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gallagher more than expected).
Fields of papers citing papers by David Gallagher
This network shows the impact of papers produced by David Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gallagher. The network helps show where David Gallagher may publish in the future.
Co-authors
The 25 scholars most cited alongside David Gallagher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 219 | |
| 2 | 2010 | 184 | |
| 3 | 2010 | 154 | |
| 4 | 2010 | 92 | |
| 5 | 2008 | 79 | |
| 6 | 2013 | 73 | |
| 7 | 2010 | 65 | |
| 8 | 2009 | 63 | |
| 9 | 2007 | 57 | |
| 10 | 2008 | 54 | |
| 11 | 2010 | 42 | |
| 12 | 2011 | 38 | |
| 13 | 2009 | 29 | |
| 14 | 1994 | 28 | |
| 15 | 2010 | 25 | |
| 16 | 2015 | 24 | |
| 17 | 2013 | 22 | |
| 18 | 2007 | 20 | |
| 19 | 2011 | 16 | |
| 20 | 2000 | 16 |
About David Gallagher
David Gallagher is a scholar working on Oncology, Surgery, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Cancer Research, having authored 103 papers that have together received 1.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (16 papers), Genetic factors in colorectal cancer (16 papers), Cancer Genomics and Diagnostics (9 papers), BRCA gene mutations in cancer (9 papers), Colorectal Cancer Treatments and Studies (7 papers), Renal cell carcinoma treatment (6 papers), Multiple and Secondary Primary Cancers (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Hepatology (165 citations), Oncology (504 citations), Cancer Research (213 citations), Pulmonary and Respiratory Medicine (391 citations) and Surgery (463 citations). David Gallagher has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Nancy E. Kemeny, Matthew I. Milowsky, Dean F. Bajorin, Jamie C. Riches, A. Trout, Nicole Ishill, Jasmine Bhatia, Ashley Marie Regazzi, Kenneth Offit and Scott R. Gerst. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Familial Cancer, Clinical Colorectal Cancer and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.